Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Cardiotoxicity × Enalapril × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Cardiotoxicity 1

Interventions

Razoxane 4 Doxorubicin 4 Dexrazoxane 4 Vincristine 3 Etoposide 3 Radiotherapy 2 Prednisone 2 Methotrexate 2 Granulocyte Colony-Stimulating Factor 2 Filgrastim 2 Bleomycin 2 hydrocortisone hemisuccinate 1 Watchful Waiting 1 Trastuzumab 1 Proton Therapy 1 Observation 1 Mercaptopurine 1 Leucovorin 1 Ifosfamide 1 Hydrocortisone 1 Enalapril 1 Cytarabine 1 Cyclophosphamide 1 Cisplatin 1 Carvedilol 1 Asparaginase 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00003070 2014-08-05

Enalapril in Treating Heart Damage Patients Who Received Anthracycline Chemotherapy for Childhood Cancer

Children's Oncology Group

Phase 3 Completed

Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡